Tackling the Next Generation of Resistance in EGFR-Mutant Lung Cancer

被引:2
|
作者
Piotrowska, Zofia [1 ]
Sequist, Lecia V. [1 ]
机构
[1] Massachusetts Gen Hosp, Ctr Canc, Boston, MA USA
关键词
ACQUIRED-RESISTANCE; INHIBITOR; HETEROGENEITY; MECHANISMS; AZD9291; MUTATIONS; THERAPY; GENE; BRAF;
D O I
10.1016/j.jtho.2017.01.018
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:419 / 421
页数:3
相关论文
共 50 条
  • [21] An EGFR ligand promotes EGFR-mutant but not KRAS-mutant lung cancer in vivo
    Tomoshige, Koichi
    Guo, Minzhe
    Tsuchiya, Tomoshi
    Fukazawa, Takuya
    Fink-Baldauf, Iris M.
    Stuart, William D.
    Naomoto, Yoshio
    Nagayasu, Takeshi
    Maeda, Yutaka
    ONCOGENE, 2018, 37 (28) : 3894 - 3908
  • [22] An EGFR ligand promotes EGFR-mutant but not KRAS-mutant lung cancer in vivo
    Koichi Tomoshige
    Minzhe Guo
    Tomoshi Tsuchiya
    Takuya Fukazawa
    Iris M. Fink-Baldauf
    William D. Stuart
    Yoshio Naomoto
    Takeshi Nagayasu
    Yutaka Maeda
    Oncogene, 2018, 37 : 3894 - 3908
  • [23] Clinical Implications of Additional Mutations Detected by Next-Generation Sequencing in EGFR-Mutant Lung Adenocarcinoma
    Kadauke, S.
    Hiemenz, M. C.
    Deshpande, C.
    Litzky, L. A.
    Roth, D. B.
    Ahmed, S.
    Aggarwal, C.
    Morrissette, J.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2014, 16 (06): : 759 - 759
  • [24] Clonal dynamics of BRAF-driven drug resistance in EGFR-mutant lung cancer
    Schaufler, Diana
    Ast, David F.
    Tumbrink, Hannah L.
    Abedpour, Nima
    Maas, Lukas
    Schwaebe, Ayla E.
    Spille, Inga
    Lennartz, Stefanie
    Fassunke, Jana
    Aldea, Mihaela
    Besse, Benjamin
    Planchard, David
    Nogova, Lucia
    Michels, Sebastian
    Kobe, Carsten
    Persigehl, Thorsten
    Westphal, Theresa
    Koleczko, Sophia
    Fischer, Rieke
    Weber, Jan-Phillip
    Altmueller, Janine
    Thomas, Roman K.
    Merkelbach-Bruse, Sabine
    Gautschi, Oliver
    Mezquita, Laura
    Buettner, Reinhard
    Wolf, Juergen
    Peifer, Martin
    Braegelmann, Johannes
    Scheffler, Matthias
    Sos, Martin L.
    NPJ PRECISION ONCOLOGY, 2021, 5 (01)
  • [25] Brain metastatic outgrowth and osimertinib resistance are potentiated by RhoA in EGFR-mutant lung cancer
    Adua, Sally J.
    Arnal-Estape, Anna
    Zhao, Minghui
    Qi, Bowen
    Liu, Zongzhi Z.
    Kravitz, Carolyn
    Hulme, Heather
    Strittmatter, Nicole
    Lopez-Giraldez, Francesc
    Chande, Sampada
    Albert, Alexandra E.
    Melnick, Mary-Ann
    Hu, Bomiao
    Politi, Katerina
    Chiang, Veronica
    Colclough, Nicola
    Goodwin, Richard J. A.
    Cross, Darren
    Smith, Paul
    Nguyen, Don X.
    NATURE COMMUNICATIONS, 2022, 13 (01)
  • [26] Clonal dynamics of BRAF-driven drug resistance in EGFR-mutant lung cancer
    Diana Schaufler
    David F. Ast
    Hannah L. Tumbrink
    Nima Abedpour
    Lukas Maas
    Ayla E. Schwäbe
    Inga Spille
    Stefanie Lennartz
    Jana Fassunke
    Mihaela Aldea
    Benjamin Besse
    David Planchard
    Lucia Nogova
    Sebastian Michels
    Carsten Kobe
    Thorsten Persigehl
    Theresa Westphal
    Sophia Koleczko
    Rieke Fischer
    Jan-Phillip Weber
    Janine Altmüller
    Roman K. Thomas
    Sabine Merkelbach-Bruse
    Oliver Gautschi
    Laura Mezquita
    Reinhard Büttner
    Jürgen Wolf
    Martin Peifer
    Johannes Brägelmann
    Matthias Scheffler
    Martin L. Sos
    npj Precision Oncology, 5
  • [27] Brain metastatic outgrowth and osimertinib resistance are potentiated by RhoA in EGFR-mutant lung cancer
    Sally J. Adua
    Anna Arnal-Estapé
    Minghui Zhao
    Bowen Qi
    Zongzhi Z. Liu
    Carolyn Kravitz
    Heather Hulme
    Nicole Strittmatter
    Francesc López-Giráldez
    Sampada Chande
    Alexandra E. Albert
    Mary-Ann Melnick
    Bomiao Hu
    Katerina Politi
    Veronica Chiang
    Nicola Colclough
    Richard J. A. Goodwin
    Darren Cross
    Paul Smith
    Don X. Nguyen
    Nature Communications, 13
  • [28] Bioinformatics-driven discovery of rational combination for overcoming EGFR-mutant lung cancer resistance to EGFR therapy
    Kim, Jihye
    Vasu, Vihas T.
    Mishra, Rangnath
    Singleton, Katherine R.
    Yoo, Minjae
    Leach, Sonia M.
    Farias-Hesson, Eveline
    Mason, Robert J.
    Kang, Jaewoo
    Ramamoorthy, Preveen
    Kern, Jeffrey A.
    Heasley, Lynn E.
    Finigan, James H.
    Tan, Aik Choon
    BIOINFORMATICS, 2014, 30 (17) : 2393 - 2398
  • [29] Acquired Resistance to EGFR tyrosine kinase inhibitors (TKIs) in EGFR-Mutant lung cancer among Hispanics (CLICaP)
    Zorrilla, A. Cardona
    Arrieta, O.
    Rojas, L.
    Corrales, L.
    Vargas, C.
    Carranza, H.
    Cuello, M.
    Martin, C.
    Rosell, R.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S15 - S15
  • [30] Targeting PKCδ as a Therapeutic Strategy against Heterogeneous Mechanisms of EGFR Inhibitor Resistance in EGFR-Mutant Lung Cancer
    Lee, Pei-Chih
    Fang, Yueh-Fu
    Yamaguchi, Hirohito
    Wang, Wei-Jan
    Chen, Tse-Ching
    Hong, Xuan
    Ke, Baozhen
    Xia, Weiya
    Wei, Yongkun
    Zha, Zhengyu
    Wang, Yan
    Kuo, Han-Pin
    Wang, Chih-Wei
    Tu, Chih-Yen
    Chen, Chia-Hung
    Huang, Wei-Chien
    Chiang, Shu-Fen
    Nie, Lei
    Hou, Junwei
    Chen, Chun-Te
    Huo, Longfei
    Yang, Wen-Hao
    Deng, Rong
    Nakai, Katsuya
    Hsu, Yi-Hsin
    Chang, Shih-Shin
    Chiu, Tai-Jan
    Tang, Jun
    Zhang, Ran
    Wang, Li
    Fang, Bingliang
    Chen, Ting
    Wong, Kwok-Kin
    Hsu, Jennifer L.
    Hung, Mien-Chie
    CANCER CELL, 2018, 34 (06) : 954 - +